Author:
Ripley R. Taylor,Holmes Hudson M.,Whitlock Richard S.,Groth Shawn S.,Medina Cristian G.,Choi Eugene A.,Burt Bryan M.,Sugarbaker Paul H.
Funder
Mesothelioma Applied Research Foundation
AstraZeneca
National Institutes of Health
National Cancer Institute
American Association for Thoracic Surgery
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference36 articles.
1. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008;Henley;Int J Occup Environ Health,2013
2. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005;Moolgavkar;Cancer Causes Control,2009
3. Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003;Price;Am J Epidemiol,2004
4. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates;Teta;Eur J Cancer Prev,2008
5. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial;Baas;Lancet,2021